Inmune Bio, Inc. (15)
Browse by Contract Category
Contracts
-
Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC
(Filed With SEC on January 4, 2021)
-
Amendment to Exclusive License Agreement
(Filed With SEC on November 5, 2020)
-
Amendment No. 1 to At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG
(Filed With SEC on August 19, 2020)
-
Underwriting Agreement, dated July 16, 2020, by and between INmune Bio, Inc. and BTIG, Inc., as representative of the underwriters named therein
(Filed With SEC on July 16, 2020)
-
INmune Bio, Inc. 2019 Stock Incentive Plan (attached hereto)
(Filed With SEC on March 11, 2020)
-
Rights Agreement, dated as of December 30, 2020, by and between INmune Bio Inc. and VStock Transfer, LLC
(Filed With SEC on December 30, 2020)
-
At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG
(Filed With SEC on April 17, 2020)
-
Award Agreement dated as of February 4, 2020
(Filed With SEC on February 10, 2020)
-
Common Stock Repurchase Agreement
(Filed With SEC on January 27, 2020)
-
Amendment No. 2 to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi
(Filed With SEC on May 24, 2019)
-
Amendment to Securities Purchase Agreement between INmune Bio, Inc. and Raymond J. Tesi
(Filed With SEC on May 17, 2019)
-
Amendment to Securities Purchase Agreement between INmune Bio, Inc. and David J. Moss
(Filed With SEC on May 17, 2019)
-
Purchase Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019
(Filed With SEC on May 16, 2019)
-
Registration Rights Agreement between INmune Bio Inc. and Lincoln Park Capital Fund, LLC, dated May 15, 2019
(Filed With SEC on May 16, 2019)
-
Award Letter dated as of February 22, 2019 from the Alzheimers Association to INmune Bio, Inc
(Filed With SEC on February 28, 2019)